A consortium led by DZNE has been tasked with investigating whether patients with “dementia of unclear etiology” benefit from examination of the brain using amyloid PET.

The scanner is intended in particular for research into the early diagnosis and treatment of dementia.

In the journal “Science”, researchers from DZNE and Charité present new findings on the immune response against SARS-CoV-2.

Long before the onset of dementia, there is evidence for increased activity of the brain’s immune system. Researchers from DZNE and the University Hospital Bonn come to this conclusion based on a study of more than 1,000 older adults.

Ahmad Aziz, scientist at DZNE’s Bonn site, has been awarded a “Starting Grant” from the European Research Council (ERC) worth around 1.5 million euros. With this funding, he aims to investigate the extent to which certain patterns in the genetic code contribute…

Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the scientific journal “Nature Communications” on the basis of laboratory experiments.

Michel Goedert is honored for his groundbreaking research on the molecular mechanisms of neurodegenerative diseases.

The Interpretation of Certain Brain Scans Needs Rethinking – Study in „Science Translational Medicine“

Levels of Certain microRNAs Indicate Risk for Cognitive Decline.

DZNE coordinates international research project on Ultra-High Field MRI.